AYT
0.003
50%
SKN
0.003
-25%
ARV
0.004
33.3%
M96
0.007
-22.2%
OMG
0.008
33.3%
FAU
0.008
-20%
SPX
0.004
33.3%
OAK
0.06
-20%
SRJ
0.009
28.6%
ACS
0.19
-17.4%
NTI
0.015
25%
AAJ
0.005
-16.7%
ZEU
0.005
25%
BNL
0.005
-16.7%
RVT
0.135
22.7%
VIT
0.026
-16.1%
CNJ
0.011
22.2%
CHM
0.011
-15.4%
EV1
0.011
22.2%
RLF
0.029
-14.7%
TMS
0.011
22.2%
ADN
0.006
-14.3%
TOR
0.265
20.5%
EMU
0.018
-14.3%
AUR
0.018
20%
ERL
0.006
-14.3%
COY
0.006
20%
JGH
0.067
-14.1%
IPD
0.006
20%
ESR
0.031
-13.9%
TIO
0.12
20%
VR1
0.019
-13.6%
BDX
0.062
19.2%
49M
0.1
-13%
AMD
0.013
18.2%
FCT
0.007
-12.5%
W2V
0.055
17%
RAG
0.022
-12%
CTT
0.28
16.7%
RCR
0.015
-11.8%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EZZ Life Science (ASX: EZZ): Targets US expansion followingFDA product approvals

Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf